Esperion Therapeutics Inc (ESPR)
2.085
+0.02
(+0.97%)
USD |
NASDAQ |
May 03, 16:00
2.08
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Revenue (Quarterly): 32.25M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.25M |
| September 30, 2023 | 33.97M |
| June 30, 2023 | 25.79M |
| March 31, 2023 | 24.33M |
| December 31, 2022 | 18.82M |
| September 30, 2022 | 18.98M |
| June 30, 2022 | 18.84M |
| March 31, 2022 | 18.84M |
| December 31, 2021 | 15.40M |
| September 30, 2021 | 14.41M |
| Date | Value |
|---|---|
| June 30, 2021 | 40.66M |
| March 31, 2021 | 7.978M |
| December 31, 2020 | 9.638M |
| September 30, 2020 | 3.833M |
| June 30, 2020 | 212.24M |
| March 31, 2020 | 1.84M |
| December 31, 2019 | 0.982M |
| September 30, 2019 | 0.981M |
| June 30, 2019 | 0.982M |
| March 31, 2019 | 145.42M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.981M
Minimum
Sep 2019
212.24M
Maximum
Jun 2020
26.36M
Average
18.82M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| United Therapeutics Corp | 677.70M |
| Dynavax Technologies Corp | 55.60M |
| Heron Therapeutics Inc | 34.23M |
| Aldeyra Therapeutics Inc | -- |
| Deciphera Pharmaceuticals Inc | 48.29M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.34M |
| Total Expenses (Quarterly) | 74.62M |
| EPS Diluted (Quarterly) | -0.50 |
| Enterprise Value | 561.48M |
| Gross Profit Margin (Quarterly) | 64.49% |
| Profit Margin (Quarterly) | -174.7% |
| Earnings Yield | -101.7% |
| Normalized Earnings Yield | -101.68 |